Board Meeting15 May 2026, 02:13 pm
Windlas Biotech Board Meeting on May 21, 2026 to Consider Results
AI Summary
Windlas Biotech Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board will also consider the recommendation of a dividend, if any. The trading window has been closed since April 1, 2026, and will reopen 48 hours after the declaration of the financial results.
Key Highlights
- Windlas Biotech board meeting set for May 21, 2026.
- Audited financial results for FY26 to be considered.
- Board to consider dividend recommendation.
- Trading window closed from April 1, 2026, reopening post results.
Price Impact
More from WINDLAS*